Next Article in Journal
Phenylpyrazolone-1,2,3-triazole Hybrids as Potent Antiviral Agents with Promising SARS-CoV-2 Main Protease Inhibition Potential
Next Article in Special Issue
Respiratory Outcomes of Insulin Use in Patients with COPD: A Nationwide Population-Based Cohort Study
Previous Article in Journal
Design, Synthesis, and Biological Evaluation of Sulfonamide Methoxypyridine Derivatives as Novel PI3K/mTOR Dual Inhibitors
Previous Article in Special Issue
Common Regulators of Lipid Metabolism and Bone Marrow Adiposity in Postmenopausal Women
 
 
Article

Article Versions Notes

Pharmaceuticals 2023, 16(3), 462; https://doi.org/10.3390/ph16030462
Action Date Notes Link
article xml file uploaded 20 March 2023 11:27 CET Original file -
article xml uploaded. 20 March 2023 11:27 CET Update -
article pdf uploaded. 20 March 2023 11:27 CET Version of Record https://www.mdpi.com/1424-8247/16/3/462/pdf-vor
article supplementary file uploaded. 20 March 2023 11:27 CET - https://www.mdpi.com/1424-8247/16/3/462#supplementary
article html file updated 20 March 2023 11:28 CET Original file -
article xml file uploaded 21 March 2023 08:06 CET Update -
article xml uploaded. 21 March 2023 08:06 CET Update -
article pdf uploaded. 21 March 2023 08:06 CET Updated version of record https://www.mdpi.com/1424-8247/16/3/462/pdf-vor
article html file updated 21 March 2023 08:08 CET Update -
article xml file uploaded 27 March 2023 12:11 CEST Update -
article xml uploaded. 27 March 2023 12:11 CEST Update https://www.mdpi.com/1424-8247/16/3/462/xml
article pdf uploaded. 27 March 2023 12:11 CEST Updated version of record https://www.mdpi.com/1424-8247/16/3/462/pdf
article html file updated 27 March 2023 12:13 CEST Update -
article html file updated 6 April 2023 21:03 CEST Update https://www.mdpi.com/1424-8247/16/3/462/html
Back to TopTop